CervoMed
CRVO
15 hedge funds and large institutions have $1.39M invested in CervoMed in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 10 closing their positions.
6.68% more ownership
Funds ownership: 0.12% → 6.8% (+6.7%)
21% less funds holding
Funds holding: 19 → 15 (-4)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
41% less capital invested
Capital invested by funds: $2.34M → $1.39M (-$958K)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$184K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$137K |
| 3 |
TI
Trexquant Investment
Stamford,
Connecticut
|
+$87.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.56K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.01K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$115K |
| 2 |
JP Morgan Chase
New York
|
-$106K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$50K |
| 4 |
Two Sigma Advisers
New York
|
-$41K |
| 5 |
YF
Yu Fan
|
-$22K |
CRVO Hedge Fund Activity: Q2 2022 in Review
15 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q2 2022, worth a combined $1.39M — down 41% from $2.34M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of CRVO and 6 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 2 added.
The largest buyer was Renaissance Technologies, adding an estimated $184K. The largest seller was State Street, exiting entirely with an estimated $115K sold.
- 15 institutional investors held CervoMed (CRVO) as of Q2 2022, down from 19 in Q1 2022.
- Funds reported $1.39M of CervoMed stock for Q2 2022, down 41% quarter-over-quarter.
- 6 funds opened new CervoMed positions in Q2 2022 and 10 closed out, a net change of -4 holders.
- The largest CervoMed buyer in Q2 2022 was Renaissance Technologies, an estimated $184K added.
- The largest CervoMed seller in Q2 2022 was State Street, an estimated $115K sold.
Based on aggregated 13F filings for Q2 2022.